LETTERS TO THE EDITOR

N Hoogerbrugge; Nicoline Hoogerbrugge; Hans Jansen; H Jansen; J C Birkenhäger

doi:10.1111/j.1365-2796.1995.tb00892.x

LETTERS TO THE EDITOR

N Hoogerbrugge, Nicoline Hoogerbrugge, Hans Jansen, H Jansen, J C Birkenhäger

Journal of internal medicine · 1995 · vol. 237(6) , pp. 603–605 · doi:10.1111/j.1365-2796.1995.tb00892.x · PMID:7782734 · W2417075017

letter OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Angioedema Danazol Endometriosis Lipoproteins Angioedema Danazol Danazol Endometriosis Female Humans Lipoproteins Lipoproteins Male

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol 1991

References (11)

Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol via openalex
W1988855503 via openalex
W1996437940 via openalex
W2004395480 via openalex
W2018430459 via openalex
W2037690190 via openalex
W2069277397 via openalex
W2316849363 via openalex
W4239590641 via openalex
W1968346685 via openalex
W4248434437 via openalex

Source provenance

europepmc: last seen: 2026-06-19T06:14:56.452680+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:11:13.665691+00:00

License: CC0 · commercial use OK

[1] Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol 1991